Tissue Engineered Collagen Biomaterials Market Is Anticipated to Reach a Value of US$5.4 Bn by 2025
Mergers, acquisitions, and distribution agreements are some of the methods leveraged by success-hungry players in the global tissue engineered collagen biomaterials market in order to grow their shares. One of the prominent manufacturers Medtronic, for instance, acquired Covidien, a global healthcare products company, in January 2016 to gain greater stronghold in the global medical device industry.
View full press release